Search results
As pharmacies disappear nationwide, Oregonians among the hardest hit
OregonLive.com· 1 day agoBrooklyn Pharmacy in Southeast Portland is a throwback to the days of mom-and-pop neighborhood...
Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger...
The Motley Fool via AOL· 2 days agoSpecifically, Wegovy was granted an expanded indication to treat patients at risk of heart disease....
10% of Medicare beneficiaries have a claim denied. Here’s how to appeal a decision
Fortune via AOL· 6 days agoCheck the Evidence of Coverage your plan sends you each year—which includes details about what’s...
Medicare drug plans are slashing drug coverage — and it’s going to impact everyone
MarketWatch via Yahoo Finance· 5 days agoIn many cases, where people are shunted onto a drug that doesn’t work for them, they end up going...
Ozempic and Wegovy Are Fueling Novo Nordisk's Business, but Something Else May Be an Even Bigger...
The Motley Fool· 2 days agoOver the last few years, some of the best-performing stocks in the broader healthcare space have...
Richard Burr: Insurance coverage for obesity can allow patients to benefit from scientific advances
Greensboro News & Record· 7 days agoPolicymakers, governments and health insurance companies should keep pace with scientific...
U.S. Senator Elizabeth Warren Warns of Anti-Competitive Behavior by Massive Insurance Companies in...
Sierra Sun Times· 1 day agoWashington, D.C. — Last Friday, U.S. Senator Elizabeth Warren (D-Mass.) sent a letter to Chiquita Brooks-LaSure, the Administrator of the Centers for Medicare and Medicaid Services (CMS), responding ...
Richard Burr: Insurance coverage for obesity can allow patients to benefit from scienfific advances
Greensboro News & Record· 7 days agoPolicymakers, governments and health insurance companies should keep pace with scientific...
Anti-Obesity Medications: Noteworthy Developments as Policymakers Weigh Coverage Considerations | JD...
JD Supra· 7 days agoGLP-1 agonists have ushered in a new era in anti-obesity medication policy considerations against the backdrop of a continued focus by policymakers on both drug access and pricing. CMS has taken ...
Doctors' Tips for Accessing Costly GLP-1 Therapies
Medscape· 2 days ago"Does your insurance cover anti-obesity drugs?" Laura Davisson, MD, once again asked the patient before her. While glucagon-like peptide 1 (GLP-1)...